Modified Release Solid Oral Dosage Forms

This chapter presents an extensive overview of the concepts of delayed-release, sustained-release, and pulsatile-release for drug delivery. Formulation approaches and delivery technologies are discussed in detail, along with the required performance testing for modified-release dosage forms. Abuse-deterrent technologies are also introduced.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic €32.70 /Month

Buy Now

Price includes VAT (France)

eBook EUR 54.99 Price includes VAT (France)

Softcover Book EUR 68.56 Price includes VAT (France)

Hardcover Book EUR 94.94 Price includes VAT (France)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Further Reading

  1. Suggested readings for the student include the following texts: Google Scholar
  2. Food and Drug Administration Center for Drugs Evaluation Research. Abuse-deterrent opioids-evaluation and labeling. Maryland: FDA; 2015. Google Scholar
  3. Conte U, Maggi L, Torre ML, Giunchedi P, La Manna A. Press-coated tablets for time-programmed release of drugs. Biomaterials. 1993;14(13):1017–23. ArticleCASGoogle Scholar
  4. Maincent J, Zhang F. Recent advances in abuse-deterrent technologies for the delivery of opioids. Int J Pharm. 2016;510(1):57–72. ArticleCASGoogle Scholar
  5. Miller DA, DiNunzio JC, Williams RO III. Advanced formulation design: improving drug therapies for the management of severe and chronic pain. Drug Dev Ind Pharm. 2008;34:117–33. ArticleCASGoogle Scholar
  6. Miller DA, Gamba M, Sauer D, Purvis TP, Clemens NT, Williams RO III. Evaluation of the USP dissolution test method a for enteric-coated articles by planar laser-induced fluorescence. Int J Pharm. 2007;330:61072. ArticleGoogle Scholar
  7. Perucca E. Extended-release formulations of antiepileptic drugs: rationale and comparative value. Epilep Curr. 2009;9(6):153–7. ArticleGoogle Scholar
  8. Rhodes CT, Porter SC. Coatings for controlled-release drug delivery systems. Drug Dev Ind Pharm. 1998;24(12):1139–54. ArticleCASGoogle Scholar
  9. Roy P, Shahiwala A. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. J Control Release. 2009;134(2):74–80. ArticleCASGoogle Scholar
  10. Verma RK, Krishna DM, Garg S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release. 2002;79(1–3):7–27. ArticleCASGoogle Scholar

Author information

Authors and Affiliations

  1. College of Pharmacy, The University of Texas at Austin, Austin, TX, USA Ashlee D. Brunaugh, Hugh D. C. Smyth & Robert O. Williams III
  1. Ashlee D. Brunaugh